CD200R signaling in infmallation and immune cancer responses: a tricky balance
2011/03/D/NZ6/03685
Keywords
Descriptors
- NZ6_1: Odporność swoista i nieswoista
- NZ6_2: Immunologia kliniczna
- NZ6_8: Inne zagadnienia pokrewne
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Warszawski Uniwersytet Medyczny, I Wydział Lekarski
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
SONATA 2 – announced on 2011-09-15
- Amount awarded
- 998 100 PLN
- Project start date
- 2012-09-17
- Project end date
- 2016-09-16
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Equipment purchased [PL]
- homogenizatora tkankowego (Gentle MACS). Cost: 23 000 PLN
- inkubator do hodowli. Cost: 27 000 PLN
- komora laminarna. Cost: 16 000 PLN
- kołyska laboratoryjna.
- wytrząsarka typu Vortex.
Information in the final report
Publication in academic press/journals (1)
-
The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies
- Authors:
- Pilch Z, Tonecka K, Skorzynski M, Sas Z, Braniewska A, Kryczka T, Boon L, Golab J, Meyaard L, Rygiel TP
- Academic press:
- PLoS One (year: 2019, volume: 14, pages: 46033), Publisher: Public Library of Science
- Status:
- Published
- DOI:
- 10.1371/journal.pone.0210796 – link to the publication